
vzphotos/iStock Editorial via Getty Images
- AbbVie (NYSE:ABBV) named Robert A. Michael as the CEO and joined AbbVie’s Board of Directors, effective today.
- Mr. Michael succeeds Richard A. Gonzalez, who has served as CEO since the company’s inception in 2013. Mr. Gonzalez has become executive chairman of the board of directors.
- Mr. Michael previously served as president and COO of AbbVie (ABBV) and has been a longstanding member of AbbVie’s executive leadership team.
- “The board and I have great confidence in Rob, and we know that his combination of experience, skills and vision uniquely prepares him to lead AbbVie,” said Richard A. Gonzalez, executive chairman.